HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kinetin sales

This article was originally published in The Rose Sheet

Executive Summary

Senetek proprietary skin care line, Kinetin Plus, will lessen dependence on licensees and capitalize on intellectual property, CEO Frank Massino says. Product line will include eight SKUs to be test marketed in spas and salons and online, exec adds during firm's May 15 first quarter sales and earnings announcement. Senetek is developing science-based educational infomercial for testing in August. Senetek sales declined 17% in Q1 to $2.1 mil., due to a reduction in product sales and royalties, company says. Royalty declines stemmed from 33% reduction in royalties from Revlon, which experienced lower than anticipated unit sales of its Almay Kinetin brand. Senetek recorded net loss of $69,000 for the three months, compared to income of $504,000 a year ago...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS011227

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel